| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LIFX | Common stock | Award | $0 | +9,091 | +0.42% | $0.000000 | 2,172,846 | 30 May 2023 | Direct | F1, F2 |
| holding | LIFX | Common stock | 30,635 | 30 May 2023 | Held by ICCA Labs, LLC | F3, F4 |
| Id | Content |
|---|---|
| F1 | Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2023, subject to the Reporting Person's continuous service through each such date. |
| F2 | Includes 10,191 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
| F3 | Represents shares of the Issuer's common stock underlying 91,905 CDIs. |
| F4 | The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 133,408 shares of the Issuer's common stock underlying 400,224 CDIs. The number of shares reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. |